Assenagon Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$78.1M Buy
997,643
+976,321
+4,579% +$66.6M 0.1% 161
2026
Q1
$1.38M Sell
21,322
-50,763
-70% -$3.58M ﹤0.01% 829
2025
Q4
$4.85M Buy
+72,085
New +$4.85M 0.01% 643
2024
Q4
Sell
-3,880
Closed -$222K 1381
2024
Q3
$222K Sell
3,880
-40,070
-91% -$2.3M ﹤0.01% 1322
2024
Q2
$2.3M Sell
43,950
-8,890
-17% -$390K 0.01% 850
2024
Q1
$2.15M Sell
52,840
-72,367
-58% -$2.71M 0.01% 868
2023
Q4
$4.63M Buy
125,207
+54,063
+76% +$2.04M 0.01% 661
2023
Q3
$2.72M Sell
71,144
-270,620
-79% -$11.1M 0.01% 747
2023
Q2
$12.3M Sell
341,764
-111,220
-25% -$3.79M 0.04% 319
2023
Q1
$17.3M Buy
452,984
+294,313
+185% +$13.8M 0.06% 269
2022
Q4
$9.03M Buy
158,671
+144,735
+1,039% +$7.41M 0.03% 405
2022
Q3
$551K Hold
13,936
﹤0.01% 1086
2022
Q2
$613K Sell
13,936
-10,857
-44% -$470K ﹤0.01% 1189
2022
Q1
$989K Sell
24,793
-97
-0.4% -$3.46K ﹤0.01% 1056
2021
Q4
$1M Buy
24,890
+2,102
+9% +$78.5K ﹤0.01% 1034
2021
Q3
$927K Buy
+22,788
New +$953K ﹤0.01% 925
2021
Q1
Sell
-235,206
Closed -$10M 1238
2020
Q4
$10M Buy
+235,206
New +$8.45M 0.04% 248

Other funds holding HALO

Assenagon Asset Management's HALO Position: Q2 2026 in Review

Assenagon Asset Management increased its Halozyme (HALO) stake by 4,579% in Q2 2026, buying an estimated $66.6M and bringing the position to 997,643 shares worth $78.1M. The position accounts for 0.1% of the portfolio, ranked #161.

Assenagon Asset Management first reported a position in HALO in Q4 2020 and has held it in 17 quarters since. 668 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Assenagon Asset Management held 997,643 shares of Halozyme worth $78.1M as of Q2 2026.
  • Assenagon Asset Management bought 976,321 Halozyme shares in Q2 2026, an estimated $66.6M.
  • Halozyme made up 0.1% of Assenagon Asset Management's portfolio in Q2 2026, its #161 holding.
  • Assenagon Asset Management first reported a position in Halozyme in Q4 2020 and has held it in 17 quarters since.
  • 668 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Assenagon Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.